"Ivabradine did produce a significant reduction in heart rate compared to placebo, but the lower heart rate did not improve POTS symptoms."
This is interesting because I've argued this for quite a while, and it fits my experience with propranolol. It lowers HR but really doesn't do much else of...
I think it makes perfect sense and when I read in the abstract that they were using prior-day symptoms and not just objective biometrics, I knew that most of the prediction skill would be due to the prior-day symptoms and not the biometrics. And that is indeed the case:
Image from @ME/CFS...
https://www.theguardian.com/politics/2026/mar/29/disabled-benefit-claimants-face-lower-payments-if-conditions-not-deemed-lifelong-charities-say
Article by Francis Ryan about the forthcoming changes to the health element of Universal Credit. Mentions ME.
A reasonably good article on the BBC focusing on some Welsh patients and the situation RE care and specialist services.
https://www.bbc.co.uk/news/articles/cpv8e71p3evo
There's also a link to a BBC Sounds / BBC Radio Wales piece with patients and the parents of a very severe patient...
It is mentioned that the BBC received feedback suggesting that the "potrayal of ME was too negative", and that one listener had writen in to suggest "there is treatment and crucially there is hope." Sounds very familiar.....
Most people won't know what this is, but if included I would call it the '2021 NICE guideline for ME/CFS'
This is a slightly awkward phrasing. I would rephrase as 'notoriously underfunded' or something to that effect.
I would not just focus on welfare spending. The way this is usually...
You might know this already, but PoTS diagnosic criteria exclude othostatic hypotension and therefore blood pressure should always be measured when testing for PoTS.
I don't know why people focus on PoTS more than OH. It would be interesting to know how prevalent each is in people with ME/CFS...
Ok, good. Well, it seems from a quick google that the answer is 'more likely'. And this is related to a known phenomenon, apparently, called polyautoimmunity (basically having two or more autoimmune conditions). The risk is higher because some AI patients have a propensity to develop more AI...
I think this is the question you are asking, and this page provides an answer: "Yes. Having one autoimmune disease slightly increases your risk of developing one or more additional autoimmune condition." (compared to the general population)...
Less likely than what, though?
That a given person is more or less likely to have 2 or more AIs than just 1? Or that a person with 1 AI is more or less likely to develop a different, second, AI than another individual developing their first AI?
Or maybe it doesn't matter now as Jonathan never...
It's so unbelieveably frustrating. I have sent many emails over the years. I have sent another one. I imagine the more they get the more likely a change to the title.
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.